Watch Ticker

Catalyst Pharmaceutical Inc.

Go to Catalyst Pharmaceutical Inc. Website

$22.22

0.49 (2.25%)

Live

Previous Close

$21.73

Day Range

$21.67 - $22.255

Previous Day Range

$21 - $21.79

Market Cap

$2.6 billion USD

Day Vol.

1.6 million

Previous Day Vol.

890842

Currency

USD

Primary Exchange

Nasdaq

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAP...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Santhera to share latest on commercial rollout of AGAMREE® and future strategic priorities at Capital Markets Day

Santhera Pharmaceuticals will provide an update on the commercial progress of its drug AGAMREE for the treatment of Duchenne Muscular Dystrophy, as well as outline its strategic plans for further market expansion and diversification of its rare disease portfolio.

Related tickers: CPRX.

Read Full Article

Zacks Equity Research - Why Is Catalyst (CPRX) Up 0.7% Since Last Earnings Report?

Catalyst (CPRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Related tickers: CPRX, ESPR.

Read Full Article

Trending Tickers

Please sign in to view